Skip to content

Dlp® 25009

by Medtronic, Inc.

Ref 25009

Dlp 25009 is a cardioplegia solution administration adaptor (EU MDD Class IIa; FDA Class II; FDA product code DWF, Catheter, Cannula and Tubing, Vascular, Cardiopulmonary Bypass) made by Medtronic, Inc., registered in EUDAMED on 6 Nov 2026 (Basic UDI-DI B-20613994918608), cleared under FDA 510(k) K182586 on 19 Oct 2018 (1 earlier submission) and listed in FDA GUDID since 22 May 2016 (UDI-DI 20613994918608), active as of 7 Nov 2026. 4 FDA recalls are linked to it.

Active European Union and United States. Also listed in GUDID (US).

CE MDD 510(k)

Valid until

No date given

CE: no date in EUDAMED. FDA: not time-limited

FDA recalls

2 ongoing

This device is named in the recall

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
European UnionCE/MDD EUDAMED NumberB-20613994918608 Basic UDI-DI 20613994918608UDI-DIDate6 Nov 2026RegisteredStatusActive
United StatesFDA 510(k)SESE GUDID from GUDID Substantially Equivalent · Special NumberK182586 Date19 Oct 2018DecidedStatusActive
United StatesGUDID listing GUDID Number20613994918608 UDI-DI Date22 May 2016ListedStatusListed GUDID: in commercial distribution

Official records

Across registries

3 registries list this device

  • EUDAMED Basic UDI-DI B-20613994918608 registered 6 Nov 2026 Active
  • FDA 510(k) K182586 decided 19 Oct 2018 Active· +1 more in the status table
  • FDA GUDID UDI-DI 20613994918608 listed 22 May 2016 Listed

Recalls

4 recalls · 2 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-1801-2024 FDA Class II initiated 19 Mar 2024
    • Ongoing Z-1800-2024 FDA Class II initiated 19 Mar 2024

    Potential for unsealed sterile packing.

  • 2 recalls, same reason

    • Terminated Z-2766-2017 FDA Class II initiated 22 Jun 2017
    • Terminated Z-2767-2017 FDA Class II initiated 22 Jun 2017

    Identification of small pinholes in a single packaging configuration of sterile pouches. A total of seven different products were affected.

Timeline

8 dated events

  1. Cleared FDA 510(k) K831591
  2. Listed FDA GUDID 20613994918608
  3. Recall initiated FDA recalls Z-2766-2017
  4. Recall initiated FDA recalls Z-2767-2017
  5. Cleared FDA 510(k) K182586
  6. Recall initiated FDA recalls Z-1801-2024
  7. Recall initiated FDA recalls Z-1800-2024
  8. Registered EUDAMED B-20613994918608

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/MDD Active
  • United States FDA 510(k) Active

Specification

EUDAMED · GUDID

Trade name
Dlp®
Generic name
Cardioplegia solution administration adaptor
Device name
DLP Pressure Monitoring Ext Line Adapter
Model / reference
25009
Primary DI / UDI-DI
20613994918608
Basic UDI-DI
B-20613994918608
510(k) Number
FDA product code
DWF
EMDN code
C0301040499 Cardioplegia cannulas - other
GMDN term
Cardioplegia solution administration adaptor
Device class
Class IIa EUDAMED
Class II GUDID
Regulation number
870.4210
EU registration type
Legacy device (under a directive)
EU market of registration
Netherlands
GUDID distribution status
In Commercial Distribution
Size
Length — 1.8 Meter

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IIa
GUDID
Class II

Device class is stated on each registry's own scale: Class IIa in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under EXTRACORPOREAL CIRCULATION CANNULAS.

Other devices from Medtronic, Inc.

See all devices from Medtronic, Inc. →

Properties

  • Supplied sterile
  • Single use
  • Lot / batch number
Other properties (22, all answered No)